Apricus Biosciences commences common stock, warrants offering
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Sustainability Outlook
The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism
Apricus Biosciences, Inc. said it began a public offering of its common shares and warrants to buy common stock.
The San Diego-based biopharmaceutical company plans to use the net proceeds for working capital and general corporate purposes.
H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.
